10-Q/A

                   SECURITIES AND EXCHANGE COMMISSION

                        Washington, D. C.  20549

                                    

                     FORM 10-Q AMENDMENT NUMBER ONE

               QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
                 OF THE SECURITIES EXCHANGE ACT OF 1934

For Quarter Ended June 30, 1995            Commission File No. 2-82655

                      INTERWEST MEDICAL CORPORATION           
         (Exact name of registrant as specified in its charter)

           Oklahoma                            75-1864474          
(State or other jurisdiction       (I.R.S. Employer Identification No.)
of incorporation or organi-
zation)
             Arlington Heights Professional Office Building
         3221 Hulen Street, Suite C, Fort Worth, TX  76107-6193
           (Address of principal executive offices, zip code)

Registrant's telephone number, including area code:  (817) 731-2743

                             Not Applicable                     
        (Former name, former address, and former fiscal year, if
                       changed since last report)

    Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days.  

                         Yes   X         No     

                 APPLICABLE ONLY TO ISSUERS INVOLVED IN
                    BANKRUPTCY PROCEEDINGS DURING THE
                          PRECEDING FIVE YEARS:

    Indicate by check mark whether the registrant has filed all
documents and reports required to be filed by Sections 12, 13 or
15(d) of the Securities Exchange Act of 1934 subsequent to the
distribution of securities under a plan confirmed by a court.  

                            (Not Applicable)

                       Yes    X          No       

                    (APPLICABLE TO CORPORATE ISSUERS)

    Indicate the number of shares outstanding of each of the
issuer's classes of common stock, as of the close of the period
covered by this report.  18,503,036 shares of Common Stock, $0.001
Par Value.  


                       PART II.  OTHER INFORMATION

Item 1.   Legal Proceedings.

          Not applicable. 

Item 2.   Changes in Securities. 

          Not applicable. 

Item 3.   Defaults upon Senior Securities.

          Not applicable.  

Item 4.   Submission of Matters to a Vote of Securities Holders.

          Not applicable. 

Item 5.   Other Information.

          Not applicable.

Item 6.   Exhibits and Reports on Form 8-K. 

               (a)  Ex(27) Financial Data Schedule.



                               SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.  

                                   INTERWEST MEDICAL CORPORATION

                              By:                                   
                                   Arch B. Gilbert, President
                                   Chief Executive Officer, 
                                   Chief Financial Officer and 
                                   Chief Accounting Officer


Date:     December 12, 1995

EX-27

 

<ARTICLE> 5
       
                             
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               JUN-30-1995
<CASH>                                       1,988,419
<SECURITIES>                                         0
<RECEIVABLES>                                1,661,939
<ALLOWANCES>                                     9,313
<INVENTORY>                                          0
<CURRENT-ASSETS>                             3,641,528
<PP&E>                                       6,309,237
<DEPRECIATION>                               1,719,179
<TOTAL-ASSETS>                               8,861,946
<CURRENT-LIABILITIES>                        1,022,089
<BONDS>                                              0
<COMMON>                                        20,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                   3,253,398
<TOTAL-LIABILITY-AND-EQUITY>                 8,861,946
<SALES>                                      4,552,442
<TOTAL-REVENUES>                             4,588,148
<CGS>                                        3,353,764
<TOTAL-COSTS>                                3,353,764
<OTHER-EXPENSES>                               558,853
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             251,941
<INCOME-PRETAX>                                423,590
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            423,590
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   423,590
<EPS-PRIMARY>                                      .02
<EPS-DILUTED>                                      .02